Celiac Disease Clinical Trials in Boston, MA

Celiac Disease Clinical Trials in Boston, MA

View the best 10 celiac disease medical studies in Boston, Massachusetts. Access promising new therapies by applying to a Boston-based Celiac Disease clinical trial.

Trials in Boston, Massachusetts

Here are the top 5 medical studies for celiac disease in Boston, Massachusetts

Image of University of Alabama at Birmingham in Birmingham, United States.

TAK-101

Immunomodulator

Recruiting0 awardsPhase 2
This trial is testing a drug called TAK-101, given through an IV, to help adults with celiac disease who still have symptoms despite following a gluten-free diet. The drug aims to reduce these symptoms by changing how the immune system reacts to gluten. TAK-101 is designed to induce gluten-specific tolerance by encapsulating gluten protein in negatively charged nanoparticles. Participants will receive the drug at different times and doses to see how well it works and how safe it is.
Image of Boston Children's Hospital in Boston, United States.

Gluten-Free Diet Education

Behavioural Intervention

Recruiting1 award
"This trial aims to show the benefits of a nutrition education program that focuses on natural gluten-free foods and limits processed gluten-free foods. The study will assess whether this education program can improve health outcomes."
Image of Massachusetts General Hospital in Boston, United States.

Ritlecitinib

Janus Kinase (JAK) Inhibitor

Recruiting0 awardsPhase 2
This trial is testing Ritlecitinib to see if it can help adults with celiac disease in remission avoid symptoms when they eat gluten. Participants will take either the drug or a non-active substance and eat a small amount of gluten regularly. The drug aims to block immune signals that cause inflammation.
Image of Children's Hospital Colorado in Aurora, United States.

Gluten Powder

Recruiting1 award1 criteria
This trial involves people with celiac disease and healthy individuals eating gluten powder to study their immune responses by measuring inflammation-related proteins in their blood.
Image of Peak Gastroenterology Associates in Colorado Springs, United States.

KAN-101

Procedure

Recruiting0 awardsPhase 2
This trial is aiming to see if KAN-101 is effective, safe, and well-tolerated in people with Celiac Disease.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.